Adial Pharmaceuticals, Inc.
USD2.74
+0.01 (+0.37%)
CEO
Cary John Claiborne
IPO Date
2018-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.72
Prev. Close
$2.73
Day Low
$2.69
Day High
$2.75
52W Low
$1.31
52W High
$19.00
Market Cap
$0.00B
Volume
0.01M
| 1,233 |
| $2.75 |
| 13 Jul 2026 | Coastlands Capital LP | 10 percent owner | P-Purchase | Acquired | 10,053 | $2.79 |
| 13 Jul 2026 | Coastlands Capital LP | 10 percent owner | P-Purchase | Acquired | 1,700 | $2.70 |
| 1 Jul 2026 | Coastlands Capital LP | 10 percent owner | P-Purchase | Acquired | 25,000 | $2.60 |
| 29 Jun 2026 | Coastlands Capital LP | 10 percent owner | Disposed | 0 | $0.00 |
| 29 Jun 2026 | Coastlands Capital LP | 10 percent owner | Disposed | 3,637,818 | $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 61,647 | $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 3,427 | $0.00 |
| 16 Jun 2026 | Davidson Matt | director, officer: Chief Development Officer | A-Award | Acquired | 232,417 | $0.00 |